175 related articles for article (PubMed ID: 6314466)
1. Current views on the diagnosis of lymphomas by surface and cytoplasmic markers.
Lewis RE; Johnson WW; Cruse JM
Surv Immunol Res; 1982; 1(2):162-72. PubMed ID: 6314466
[No Abstract] [Full Text] [Related]
2. Nodular lymphocyte predominance type of Hodgkin's disease is a B cell lymphoma.
Poppema S; Timens W; Visser L
Adv Exp Med Biol; 1985; 186():963-9. PubMed ID: 2931963
[No Abstract] [Full Text] [Related]
3. Cell surface markers in leukemia: biological and clinical correlations.
Thiel E
Crit Rev Oncol Hematol; 1985; 2(3):209-60. PubMed ID: 3013441
[TBL] [Abstract][Full Text] [Related]
4. Surface markers on leukemia and lymphoma cells: recent advances.
Foon KA; Schroff RW; Gale RP
Blood; 1982 Jul; 60(1):1-19. PubMed ID: 6805534
[No Abstract] [Full Text] [Related]
5. The cellular content of non Hodgkin lymphomas: a comprehensive analysis using monoclonal antibodies and other surface marker techniques.
Habeshaw JA; Bailey D; Stansfeld AG; Greaves MF
Br J Cancer; 1983 Mar; 47(3):327-51. PubMed ID: 6338896
[TBL] [Abstract][Full Text] [Related]
6. Malignant lymphomas as tumours of the immune system.
Berard CW; Cossman J; Jaffe ES
Br J Cancer; 1980 Jul; 42(1):1-20. PubMed ID: 7000112
[TBL] [Abstract][Full Text] [Related]
7. Ia antigen expression by human malignant lymphomas: correlation with conventional lymphoid markers.
Halper JP; Knowles DM; Wang CY
Blood; 1980 Mar; 55(3):373-82. PubMed ID: 6766752
[No Abstract] [Full Text] [Related]
8. Detection of T and B cell populations in some lymphoproliferative disorders.
Herzog P; Stöckbauer P
Czech Med; 1980; 3(4):263-70. PubMed ID: 6971744
[TBL] [Abstract][Full Text] [Related]
9. Malignant lymphomas.
Tindle BH
Am J Pathol; 1984 Jul; 116(1):119-74. PubMed ID: 6377907
[No Abstract] [Full Text] [Related]
10. [Morphologic and immunologic criteria for the diagnosis of non-Hodgkin's lymphoma of low-grade malignancy].
Odermatt BF; Maurer R; Rüttner JR
Schweiz Rundsch Med Prax; 1986 Apr; 75(15):401-7. PubMed ID: 3485809
[No Abstract] [Full Text] [Related]
11. 2. Lymphocyte surface marker studies in lymphoma and leukemia.
Lowenthal RM
Pathology; 1982 Jul; 14(3):283-9. PubMed ID: 6752833
[TBL] [Abstract][Full Text] [Related]
12. Immunologic basis for the redefinition of malignant lymphomas.
Parker JW
Am J Clin Pathol; 1979 Oct; 72(4 Suppl):670-86. PubMed ID: 386778
[TBL] [Abstract][Full Text] [Related]
13. Current concepts in immunology: Cell-surface markers in lymphoproliferative disease.
Aisenberg AC
N Engl J Med; 1981 Feb; 304(6):331-6. PubMed ID: 6969365
[No Abstract] [Full Text] [Related]
14. Differentiation between benign and malignant human lymph nodes by means of immunologic markers.
Brubaker DB; Whiteside TL
Cancer; 1979 Apr; 43(4):1165-76. PubMed ID: 376086
[TBL] [Abstract][Full Text] [Related]
15. Detection of intracellular and cell surface immunoglobulin in non-Hodgkin's lymphoma.
Davey FR; Halliday D; Marucci AA; Gottlieb AJ
Hum Pathol; 1978 May; 9(3):285-94. PubMed ID: 350755
[No Abstract] [Full Text] [Related]
16. Immunologic definition of lymphocytes: functions and markers.
Stathopoulos G; Davies AJ
Recent Results Cancer Res; 1976; (56):17-23. PubMed ID: 1087443
[No Abstract] [Full Text] [Related]
17. Cell markers and the classification of acute leukaemia.
Catovsky D; Galton DA
Haematol Blood Transfus; 1977; 20():25-31. PubMed ID: 305399
[No Abstract] [Full Text] [Related]
18. Malignant lymphomas: cell surface markers and advances in classification.
Strauchen JA
West J Med; 1981 Oct; 135(4):276-84. PubMed ID: 6979127
[TBL] [Abstract][Full Text] [Related]
19. Surface receptors of human neoplastic lymphoreticular cells.
Braylan RC; Jaffe ES; Mann RB; Frank MM; Berard CW
Haematol Blood Transfus; 1977; 20():47-53. PubMed ID: 344164
[No Abstract] [Full Text] [Related]
20. Lymphocyte surface markers.
Thomson AW
Scott Med J; 1979 Apr; 24(2):118-20. PubMed ID: 315100
[No Abstract] [Full Text] [Related]
[Next] [New Search]
